Catalyst Wire Dossier Catalyst Wire Dossier

VoSpire ER Tablets 8 mg

albuterol sulfate · Mylan Pharmaceuticals Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VoSpire ER Tablets 8 mg, covering 2008-04-01 to 2008-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Fasting Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg [Phase 1]

See pricing